SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
SAN DIEGO, CA, March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company ...
SAN DIEGO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
SAN DIEGO, Jan. 22, 2020 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today ...
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the company ...
AXIM Biotechnolgies, Inc. is beginning human dermatological clinical trials for Cannabinoid based solutions for psoriasis and eczema. The trials will be conducted at The Maurits Clinic in The Hague, ...
SAN DIEGO--(BUSINESS WIRE)--AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today ...
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s “We’re in the diagnostic solutions segment using teardrops and have ...
During the last few years of the COVID-19 pandemic, the term “rapid test” conjures images of overlong cotton swabs reaching heretofore untouched corners of nasal cavities. In reality, rapid tests aid ...
Axim Biotechnologies Inc. Annual stock financials by MarketWatch. View the latest AXIM financial statements, income statements and financial ratios.